PubMed:13679858
Annnotations
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-118 | Sentence | denotes | Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. |
TextSentencer_T2 | 119-265 | Sentence | denotes | Suppression of tropomyosins (TMs), a family of actin-binding, microfilament-associated proteins, is a prominent feature of many transformed cells. |
TextSentencer_T3 | 266-336 | Sentence | denotes | Yet it is unclear whether downregulation of TMs occur in human tumors. |
TextSentencer_T4 | 337-478 | Sentence | denotes | We have investigated the expression of tropomyosin-1 (TM1) in human breast carcinoma tissues by in situ hybridization and immunofluorescence. |
TextSentencer_T5 | 479-548 | Sentence | denotes | TM1 mRNA and protein are readily detectable in normal mammary tissue. |
TextSentencer_T6 | 549-625 | Sentence | denotes | In contrast, TM1 expression is abolished in the primary human breast tumors. |
TextSentencer_T7 | 626-697 | Sentence | denotes | Expression of other TM isoforms, however, is variable among the tumors. |
TextSentencer_T8 | 698-823 | Sentence | denotes | The consistent and profound downregulation of TM1 suggests that TM1 may be a novel and useful biomarker of mammary neoplasms. |
TextSentencer_T9 | 824-994 | Sentence | denotes | These data also support the hypothesis that suppression of TM1 expression during the malignant conversion of mammary epithelium as a contributing factor of breast cancer. |
TextSentencer_T10 | 995-1141 | Sentence | denotes | In support of this hypothesis, we show that the ability to suppress malignant growth properties of breast cancer cells is specific to TM1 isoform. |
TextSentencer_T11 | 1142-1296 | Sentence | denotes | Investigations into the mechanisms of TM1-induced tumor suppression reveal that TM1 induces anoikis (detachment induced apoptosis) in breast cancer cells. |
TextSentencer_T12 | 1297-1525 | Sentence | denotes | Downregulation of TM1 in breast tumors may destabilize microfilament architecture and confer resistance to anoikis, which facilitates survival of neoplastic cells outside the normal microenvironment and promote malignant growth. |
T1 | 0-118 | Sentence | denotes | Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. |
T2 | 119-265 | Sentence | denotes | Suppression of tropomyosins (TMs), a family of actin-binding, microfilament-associated proteins, is a prominent feature of many transformed cells. |
T3 | 266-336 | Sentence | denotes | Yet it is unclear whether downregulation of TMs occur in human tumors. |
T4 | 337-478 | Sentence | denotes | We have investigated the expression of tropomyosin-1 (TM1) in human breast carcinoma tissues by in situ hybridization and immunofluorescence. |
T5 | 479-548 | Sentence | denotes | TM1 mRNA and protein are readily detectable in normal mammary tissue. |
T6 | 549-625 | Sentence | denotes | In contrast, TM1 expression is abolished in the primary human breast tumors. |
T7 | 626-697 | Sentence | denotes | Expression of other TM isoforms, however, is variable among the tumors. |
T8 | 698-823 | Sentence | denotes | The consistent and profound downregulation of TM1 suggests that TM1 may be a novel and useful biomarker of mammary neoplasms. |
T9 | 824-994 | Sentence | denotes | These data also support the hypothesis that suppression of TM1 expression during the malignant conversion of mammary epithelium as a contributing factor of breast cancer. |
T10 | 995-1141 | Sentence | denotes | In support of this hypothesis, we show that the ability to suppress malignant growth properties of breast cancer cells is specific to TM1 isoform. |
T11 | 1142-1296 | Sentence | denotes | Investigations into the mechanisms of TM1-induced tumor suppression reveal that TM1 induces anoikis (detachment induced apoptosis) in breast cancer cells. |
T12 | 1297-1525 | Sentence | denotes | Downregulation of TM1 in breast tumors may destabilize microfilament architecture and confer resistance to anoikis, which facilitates survival of neoplastic cells outside the normal microenvironment and promote malignant growth. |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
13679858-0#22#35#gene7168 | 22-35 | gene7168 | denotes | tropomyosin-1 |
13679858-0#104#117#diseaseC1458155 | 104-117 | diseaseC1458155 | denotes | breast tumors |
13679858-10#38#41#gene7168 | 1180-1183 | gene7168 | denotes | TM1 |
13679858-10#80#83#gene7168 | 1222-1225 | gene7168 | denotes | TM1 |
13679858-10#134#147#diseaseC0006142 | 1276-1289 | diseaseC0006142 | denotes | breast cancer |
13679858-10#134#147#diseaseC0678222 | 1276-1289 | diseaseC0678222 | denotes | breast cancer |
13679858-10#134#147#diseaseC0006142 | 1276-1289 | diseaseC0006142 | denotes | breast cancer |
13679858-10#134#147#diseaseC0678222 | 1276-1289 | diseaseC0678222 | denotes | breast cancer |
22#35#gene7168104#117#diseaseC1458155 | 13679858-0#22#35#gene7168 | 13679858-0#104#117#diseaseC1458155 | associated_with | tropomyosin-1,breast tumors |
38#41#gene7168134#147#diseaseC0006142 | 13679858-10#38#41#gene7168 | 13679858-10#134#147#diseaseC0006142 | associated_with | TM1,breast cancer |
38#41#gene7168134#147#diseaseC0678222 | 13679858-10#38#41#gene7168 | 13679858-10#134#147#diseaseC0678222 | associated_with | TM1,breast cancer |
38#41#gene7168134#147#diseaseC0006142 | 13679858-10#38#41#gene7168 | 13679858-10#134#147#diseaseC0006142 | associated_with | TM1,breast cancer |
38#41#gene7168134#147#diseaseC0678222 | 13679858-10#38#41#gene7168 | 13679858-10#134#147#diseaseC0678222 | associated_with | TM1,breast cancer |
80#83#gene7168134#147#diseaseC0006142 | 13679858-10#80#83#gene7168 | 13679858-10#134#147#diseaseC0006142 | associated_with | TM1,breast cancer |
80#83#gene7168134#147#diseaseC0678222 | 13679858-10#80#83#gene7168 | 13679858-10#134#147#diseaseC0678222 | associated_with | TM1,breast cancer |
80#83#gene7168134#147#diseaseC0006142 | 13679858-10#80#83#gene7168 | 13679858-10#134#147#diseaseC0006142 | associated_with | TM1,breast cancer |
80#83#gene7168134#147#diseaseC0678222 | 13679858-10#80#83#gene7168 | 13679858-10#134#147#diseaseC0678222 | associated_with | TM1,breast cancer |
DisGeNet-2017-sample
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2077 | 1180-1183 | gene:7168 | denotes | TM1 |
T2078 | 1276-1289 | disease:C0006142 | denotes | breast cancer |
T2079 | 1222-1225 | gene:7168 | denotes | TM1 |
R1 | T2077 | T2078 | associated_with | TM1,breast cancer |
R2 | T2077 | T2078 | associated_with | TM1,breast cancer |
R3 | T2079 | T2078 | associated_with | TM1,breast cancer |
R4 | T2079 | T2078 | associated_with | TM1,breast cancer |
UBERON-AE
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 104-110 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T2 | 405-411 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T3 | 611-617 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T4 | 980-986 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T5 | 1094-1100 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T6 | 1276-1282 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T7 | 1322-1328 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T8 | 422-429 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
PD-UBERON-AE-B_T9 | 541-547 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T10 | 941-951 | http://purl.obolibrary.org/obo/UBERON_0000483 | denotes | epithelium |
performance-test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-UBERON-AE-B_T1 | 422-429 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
PD-UBERON-AE-B_T2 | 541-547 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissue |
PD-UBERON-AE-B_T3 | 104-110 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T4 | 405-411 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T5 | 611-617 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T6 | 980-986 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T7 | 1094-1100 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T8 | 1276-1282 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T9 | 1322-1328 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
PD-UBERON-AE-B_T10 | 941-951 | http://purl.obolibrary.org/obo/UBERON_0000483 | denotes | epithelium |
DisGeNET
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T0 | 562-565 | gene:7168 | denotes | TM1 |
T1 | 611-624 | disease:C1458155 | denotes | breast tumors |
R1 | T0 | T1 | associated_with | TM1,breast tumors |